Executive Summary
The three contracts analyzed total $5.195 billion, all from civilian agencies with no defense exposure, signaling a significant shift in government spending toward health and intellectual property services. The dominant theme is a massive $4.81 billion Leidos Biomedical Research contract from HHS, which is the highest-conviction signal but lacks pricing and competition details, creating uncertainty.
A $191.9 million Cardinal Intellectual Property contract from the USPTO offers long-term revenue visibility but has zero outlayed funds, raising execution risk. The $190 million OptumServe VA contract is nearly fully executed, indicating strong cash flow realization. Key risks include the lack of defense contracts, which may underweight sector exposure, and the need to monitor the Leidos contract's activation and Cardinal's revenue recognition.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Contract Deobligations Alert digest from July 12, 2026.
Investment Signals (3)
- Leidos Biomedical Research Secures $4.81B HHS Contract, Dominating Civilian Health Spending (MEDIUM)▲
Leidos Biomedical Research Inc. received a $4.81 billion defense contract from HHS, representing 92.6% of total obligation value. This suggests strong positioning in biomedical research, but the lack of pricing and competition details warrants caution.
- Cardinal Intellectual Property Wins $191.9M USPTO Contract with Zero Outlayed Funds (MEDIUM)▲
Cardinal Intellectual Property Inc. secured a $191.9 million firm-fixed-price contract for Patent Cooperation Treaty services over 13 years, but no funds have been outlayed, implying delayed revenue recognition or contract inactivity.
- OptumServe's $190M VA Contract Nearly Fully Executed, Demonstrating Strong Cash Flow (HIGH)▲
OptumServe Health Services, a UnitedHealth Group subsidiary, executed 92.4% of its $190 million VA medical disability examination contract, indicating successful cost management and revenue realization.
Risk Flags (3)
- Execution [HIGH RISK]▼
Cardinal Intellectual Property's $191.9M USPTO contract has $0 outlayed, suggesting potential delays in contract activation or performance issues.
- Concentration [CRITICAL RISK]▼
The $4.81B Leidos Biomedical contract from HHS represents 92.6% of total obligation value, creating extreme single-contract concentration risk for Leidos if performance falters or budget cuts occur.
- Budget [MEDIUM RISK]▼
All three contracts are civilian (HHS, USPTO, VA), with no defense exposure. Civilian agency budgets face higher risk of sequestration or discretionary cuts compared to DOD.
Opportunities (2)
- ◆
Leidos Biomedical's $4.81B HHS contract signals potential for expanded biomedical research services, especially in pandemic preparedness or NIH-related work.
- ◆
OptumServe's successful execution of the $190M VA contract positions UnitedHealth Group for recompetition or expansion into other VA regions for disability exams.
Sector Themes (2)
- ◆
The digest shows zero defense contracts and $5.195B in civilian awards, with health services (Leidos, OptumServe) and IP services (Cardinal) dominating. This suggests a shift in government spending toward non-defense priorities.
- ◆
Both Cardinal ($191.9M) and OptumServe ($190M) contracts are firm-fixed-price, transferring cost overrun risk to contractors. OptumServe's high outlay rate suggests successful risk management, while Cardinal's zero outlay raises concerns.
Watch List (3)
- 👁
{"entity"=>"Leidos Holdings Inc.", "reason"=>"Massive $4.81B HHS contract with limited details; needs monitoring for activation and performance.", "trigger"=>"Contract modification announcements or HHS budget hearings"}
- 👁
{"entity"=>"Cardinal Intellectual Property Inc.", "reason"=>"$191.9M USPTO contract with zero outlayed funds; potential revenue recognition delay.", "trigger"=>"Quarterly outlay reports or SEC filings showing revenue from this contract"}
- 👁
{"entity"=>"UnitedHealth Group Inc.", "reason"=>"OptumServe's $190M VA contract nearly complete; watch for recompetition or new awards.", "trigger"=>"New VA solicitations for medical disability exams in Southeast region"}
Get daily alerts with 3 investment signals, 3 risk alerts, 2 opportunities and full AI analysis of all 3 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Contract Deobligations Alert
🇺🇸 More from United States
View all →July 13, 2026
US Pre-Market SEC Filings Roundup — July 13, 2026
US Pre-Market SEC Filings Roundup
July 13, 2026
S&P 500 Financials Sector SEC Filings — July 13, 2026
S&P 500 Financials Sector SEC Filings
July 13, 2026
US Activist Hedge Fund Institutional SEC 13D 13G — July 13, 2026
US Activist Hedge Fund Institutional SEC 13D 13G
July 13, 2026
Nasdaq 100 Stocks SEC Filings — July 13, 2026
Nasdaq 100 Stocks SEC Filings